First Trust Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.24M | Sell |
|
|||||
|
2025
Q1 | $6.41M | Sell |
|
|||||
|
2024
Q4 | $49.9M | Buy |
|
|||||
|
2024
Q3 | $7.3M | Sell |
|
|||||
|
2024
Q2 | $56M | Sell |
|
|||||
|
2024
Q1 | $65.8M | Buy |
|
|||||
|
2023
Q4 | $7.33M | Sell |
|
|||||
|
2023
Q3 | $13.8M | Buy |
|
|||||
|
2023
Q2 | $11.7M | Sell |
|
|||||
|
2023
Q1 | $23.8M | Buy |
|
|||||
|
2022
Q4 | $7.73M | Sell |
|
|||||
|
2022
Q3 | $66.7M | Buy |
|
|||||
|
2022
Q2 | $206K | Sell |
|
|||||
|
2022
Q1 | $61.8M | Sell |
|
|||||
|
2021
Q4 | $62.5M | Sell |
|
|||||
|
2021
Q3 | $56.9M | Sell |
|
|||||
|
2021
Q2 | $60.1M | Sell |
|
|||||
|
2021
Q1 | $55.6M | Buy |
|
|||||
|
2020
Q4 | $52.7M | Sell |
|
|||||
|
2020
Q3 | $53.4M | Buy |
|
|||||
|
2020
Q2 | $44.8M | Buy |
|
|||||
|
2020
Q1 | $40.3M | Sell |
|
|||||
|
2019
Q4 | $48.4M | Buy |
|
|||||
|
2019
Q3 | $202K | Sell |
|
|||||
|
2019
Q2 | $216K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $937K | Sell |
|
|||||
|
2018
Q3 | $24.1M | Buy |
|
|||||
|
2018
Q2 | $21.5M | Buy |
|
|||||
|
2018
Q1 | $475K | Sell |
|
|||||
|
2017
Q4 | $1.55M | Buy |
|
|||||
|
2017
Q3 | $898K | Sell |
|
|||||
|
2017
Q2 | $2.17M | Sell |
|
|||||
|
2017
Q1 | $19.7M | Buy |
|
|||||
|
2016
Q4 | $15.3M | Buy |
|
|||||
|
2016
Q3 | $12.5M | Buy |
|
|||||
|
2016
Q2 | $672K | Sell |
|
|||||
|
2016
Q1 | $1.3M | Buy |
|
|||||
|
2015
Q4 | $1.01M | Sell |
|
|||||
|
2015
Q3 | $2.37M | Buy |
|
|||||
|
2015
Q2 | $1.53M | Buy |
|
|||||
|
2015
Q1 | $627K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $282K | Sell |
|
|||||
|
2014
Q2 | $941K | Buy |
|
|||||
|
2014
Q1 | $787K | Buy |
|
|||||
|
2013
Q4 | $525K | Sell |
|
|||||
|
2013
Q3 | $510K | Buy |
|